Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Pollution exposure speeds up hair damage.

Minoxidil in breast milk may harm nursing infants.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Honokiol helps protect skin from damage and aging caused by cigarette smoke.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Amitraz effectively treated sarcoptic mange in three alpacas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Some psychiatric drugs can cause skin problems, but serious reactions are rare.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

New treatments for lupus show promise, but more research is needed, especially for children.

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

Stopping minoxidil caused significant hair loss, but regrowth occurred after resuming use.

Using micro skin tissue columns improves skin wound healing and reduces scarring.

A new method was created to measure metformin in hair, showing potential for monitoring treatment and medical investigations.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Zinc oxide nanoparticle biscuits improved growth and health in zinc-deficient rats without toxicity.